Management of Patients with Psychostimulant Use Problems. Guidelines for General Practitioners
Published by Commonwealth Department of Health and Ageing
2004
These guidelines have been developed to coincide with the update of the National Drug Strategy Monograph No 51, Second Edition, Models of intervention and care for psychostimulant users. Their purpose is to provide guidelines for general practitioners throughout Australia to effectively and safely manage individuals who are experiencing problems related to the use of psychostimulants, including psychostimulant and serotonin toxicity.
The aim of the guidelines is to assist general practitioners to identify patients who may be using psychostimulants; engage psychostimulant users in treatment; and identify and manage a range of adverse consequences of stimulant use including acute toxicity.
Management of Patients with Psychostimulant Use Problems. Guidelines for General Practitioners (PDF 435 KB)
Page currency, Latest update: 02 November, 2004
Help with accessing large files
When accessing large files (over 500 KB in size), it is recommended that the following procedure be used:
- Click the link with the RIGHT mouse button
- Choose "Save Target As.../Save Link As..." depending on your browser
- Select an appropriate folder on a local drive to place the downloaded file
Attempting to open large files within the browser window (by left-clicking)
may inhibit your ability to continue browsing while the document is
opening and/or lead to system problems.
Help with accessing PDF documents
To
view PDF (Portable
Document Format) documents, you will need to have a PDF reader
installed on your computer. The Adobe Acrobat Reader is available free
of charge from Adobe's
website.
If you are having difficulty downloading the PDF document(s) please email IGCD@health.gov.au and we will arrange for an alternative format or a copy to be sent to you.

